...
首页> 外文期刊>Haematologica >Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation | Haematologica
【24h】

Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation | Haematologica

机译:正在进行的移植物抗宿主病是异基因造血干细胞移植后无精子症的危险因素:欧洲血液和骨髓移植小组晚期效应工作组的一项调查|血液学

获取原文
           

摘要

The aim of this study was to assess the degree of spermatogenesis defects in sperm analysis in long-term male survivors after allogeneic hematopoietic stem cell transplantation in order to identify the risk factors related to potential infertility after hematopoietic stem cell transplantation and to provide data on longitudinal sperm recovery after hematopoietic stem cell transplantation. Here, the Late Effects Working Party of the European Group for Blood and Marrow Transplantation reports data of sperm analysis from 224 males who underwent hematopoietic stem cell transplantation. Median time between transplantation and sperm analysis was 63 months (8–275 months). At last sperm analysis, presence of any degree of spermatozoa was reported in 70 (31%) and complete azoospermia in 154 (69%) patients. In multivariate analysis, being conditioned with total body irradiation (RR 7.1; 95% CI: 3.4–14.8) and age over 25 years at transplantation (RR 2.4; 95% CI: 1.09–5.2) were significantly associated with higher risk for azoospermia. In patients not conditioned with total body irradiation, ongoing chronic graft-versus-host disease is the main adverse factor for sperm recovery (RR of 3.11; 95% CI: 1.02–9.47; P=0.045). Already established risk factors, such as total body irradiation and age older than 25 years at hematopoietic stem cell transplantation, were seen to be the most relevant adverse risk factor for sperm production after hematopoietic stem cell transplantation. Furthermore, for the first time, ongoing graft-versus-host disease has been shown to be the most relevant adverse factor for sperm recovery, particularly in patients conditioned without total body irradiation. We also introduce a useful scoring system to predict the probability of male long-term survivors’ azoospermia.
机译:本研究的目的是评估同种异体造血干细胞移植后长期男性幸存者精子分析中精子发生缺陷的程度,以鉴定与造血干细胞移植后潜在不育有关的危险因素,并提供纵向数据造血干细胞移植后精子恢复。在这里,欧洲血液和骨髓移植小组的后期效应工作组报告了来自224位进行了造血干细胞移植的男性精子分析的数据。移植和精子分析之间的中位时间为63个月(8-275个月)。在最后一次精子分析中,有70位(31%)的精子发生了任何程度的报告,154位(69%)的患者出现了完全无精子症。在多变量分析中,接受全身照射(RR 7.1; 95%CI:3.4-14.8)和移植时超过25年的年龄(RR 2.4; 95%CI:1.09-5.2)与无精子症的高风险显着相关。对于未接受全身照射的患者,进行中的慢性移植物抗宿主疾病是精子恢复的主要不利因素(RR为3.11; 95%CI:1.02-9.47; P = 0.045)。已经确定的危险因素,例如造血干细胞移植的全身照射和年龄大于25岁,是造血干细胞移植后产生精子的最相关的不利危险因素。此外,首次显示,进行中的移植物抗宿主病是精子恢复最相关的不利因素,特别是在没有全身照射的情况下。我们还引入了一种有用的评分系统来预测男性长期幸存者无精子症的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号